SXI Life Sciences
7.535,19
PKT
-19,39
PKT
-0,26
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.03.10 | Novartis kaufen | Deutsche Bank AG | |
| 25.02.10 | Novartis kaufen | Independent Research GmbH | |
| 18.02.10 | Novartis kaufen | JP Morgan Chase & Co. | |
| 02.02.10 | Novartis kaufen | Exane-BNP Paribas SA | |
| 29.01.10 | Novartis kaufen | Frankfurter Tagesdienst | |
| 29.01.10 | Novartis halten | Raiffeisen Centrobank AG | |
| 27.01.10 | Novartis kaufen | National-Bank AG | |
| 27.01.10 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 27.01.10 | Novartis halten | Independent Research GmbH | |
| 26.01.10 | Novartis kaufen | SEB AG | |
| 21.01.10 | Novartis halten | Independent Research GmbH | |
| 11.01.10 | Lonza kaufen | Die Actien-Börse | |
| 07.01.10 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 07.01.10 | Novartis halten | Credit Suisse Group | |
| 05.01.10 | Novartis kaufen | Citigroup Corp. | |
| 05.01.10 | Novartis halten | Société Générale Group S.A. (SG) | |
| 06.01.10 | Novartis kaufen | UBS AG | |
| 04.01.10 | Novartis halten | Independent Research GmbH | |
| 04.01.10 | Novartis halten | SEB AG | |
| 23.12.09 | Novartis buy | Helvea | |
| 10.12.09 | Novartis hold | Société Générale Group S.A. (SG) | |
| 11.12.09 | Novartis buy | Citigroup Corp. | |
| 09.12.09 | BB Biotech kaufen | Hamburger Sparkasse AG (Haspa) | |
| 09.12.09 | Novartis akkumulieren | Independent Research GmbH | |
| 09.12.09 | Novartis buy | Helvea | |
| 11.12.09 | Novartis buy | Goldman Sachs Group Inc. | |
| 08.12.09 | Novartis buy | Citigroup Corp. | |
| 03.12.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 03.12.09 | Novartis buy | UBS AG | |
| 30.11.09 | Novartis buy | Helvea | |
| 26.11.09 | Novartis underperform | Cheuvreux SA | |
| 25.11.09 | Novartis outperform | Exane-BNP Paribas SA | |
| 24.11.09 | Novartis buy | Goldman Sachs Group Inc. | |
| 24.11.09 | BB Biotech | Wirtschaftswoche | |
| 24.11.09 | Novartis overweight | JP Morgan Chase & Co. | |
| 17.11.09 | Novartis akkumulieren | Independent Research GmbH | |
| 17.11.09 | Novartis | Wirtschaftswoche | |
| 16.11.09 | Novartis equal-weight | Morgan Stanley | |
| 13.11.09 | Novartis underweight | Barclays Capital | |
| 13.11.09 | Novartis | Focus Money |